loader
Please Wait
Applying Filters...

Looking for Granulation? Find Granulation Agents used in Pyrazinamide to address drug delivery challenges on PharmaCompass.

Menu
$ API Ref.Price (USD/KG) : 19Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1SPI Pharma

02 1Faran Shimi Pharmaceutical

03 23BASF

04 1Ingredion Pharma Solutions

05 1Microlex e.U

06 2Pharmatrans-Sanaq

07 1Pluviaendo

08 1Prachin Chemical

09 4Sigachi Industries

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSPI Pharma has been solving formulation challenges using superior functional materials.

Grade : Oral

Brand Name : Aluminum Hydroxide 0200

Excipient Details : Aluminum hydroxide dried gel product (powder) 0200 is typically used in wet granulation processes to manufacture antacid tablets.

Pharmacopoeia Ref : USP, EP

Technical Specs : Tapped Density: 0.16-0.25, PSD D50: 12

Grade : Oral

arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSPI Pharma has been solving formulation challenges using superior functional materials.

Dosage Form : Tablet

Category : Granulation

Brand : ALUMINUM HYDROXIDE 0200

Applications : Aluminum hydroxide dried gel product (powder) 0200 is typically used in wet granulation processes to manufacture antacid tablets.

Pharmacopoeia Ref : USP, EP

Technical Specs : Tapped Density: 0.16-0.25, PSD D50: 12

Grade : Oral

arrow

02

arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothFaran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.

Grade : Oral

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothFaran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.

Dosage Form : Tablet

Category : Granulation

04

arrow
Fi Europe 2024
Not Confirmed

05

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

Brand : KOLLIDON SR

Applications : For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.

Pharmacopoeia Ref : Ph. Eur., USP-NF, JP-JPE: 80 % Polyvinyl acetate and 19 % povidone, 0.8 % lauryl sulfate & 0.2 % silica (4:1)

Technical Specs : Not Available

Grade : Not Available

arrow
blank

09

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed
blank

11

arrow
Fi Europe 2024
Not Confirmed

12

arrow
Fi Europe 2024
Not Confirmed

13

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed
blank

15

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed
blank

19

arrow
Fi Europe 2024
Not Confirmed